Does Medicare Part D Suboxone & Buprenorphine Coverage Cover Rehab?
Medicare Part D (Prescription Drug Coverage) covers prescription buprenorphine for opioid use disorder (OUD) including generic sublingual buprenorphine-naloxone (Suboxone film/tablet), brand-name Suboxone, and Sublocade...
- Free & confidential
- 24/7 availability
- Verified in 5 min
- HIPAA-compliant
- No pressure, just answers
⚡ Quick Answer
Yes, Medicare Part D Suboxone & Buprenorphine Coverage covers addiction treatment. Under the Mental Health Parity Act, Medicare Part D Suboxone & Buprenorphine Coverage must cover substance use disorder treatment — including Generic sublingual buprenorphine-naloxone (Suboxone film/tablet), Brand-name Suboxone film, Sublocade extended-release buprenorphine injection, Subutex (buprenorphine mono-product), and more. 4 plan types accepted. Average out-of-pocket: $0–$5,000. Call (833) 546-3513 for free verification.
Compare with other providers
Medicare Part D Suboxone & Buprenorphine Coverage for addiction treatment: pros & cons
Real-world strengths and trade-offs to consider when planning treatment.
Pros
- Generic buprenorphine $0-$10 copay on most preferred tiers in 2026
- CMS opioid use disorder benefit prioritizes generic MAT access
- Medicare Extra Help (LIS) eliminates copays for income-eligible
- Coverage across all 50 states uniformly
- Standalone Part D plans available regardless of Original Medicare or MA enrollment
- Specialty pharmacy delivery available for Sublocade and brand products
- Naloxone (Narcan) covered as overdose reversal medication
- Tier-1 generic buprenorphine on virtually all 2026 Part D formularies
Cons
- Brand Suboxone and Sublocade typically require prior auth
- Step-therapy may require generic trial before brand approval
- Part D coverage gap ("donut hole") affects high-cost users (largely eliminated post-2025 ACA)
- Original Medicare beneficiaries need separate Part D enrollment
- Standalone PDP premium $30-$50/month additional cost
- Methadone NOT covered by Part D (Part B at OTPs only)
- Some specialty pharmacies require mail-order rather than retail
Detailed Medicare Part D Suboxone & Buprenorphine Coverage coverage analysis
Part D buprenorphine formulary structure
Generic sublingual buprenorphine-naloxone (Suboxone film/tablet) is on the preferred tier (tier-1 or tier-2) of virtually all 2026 Part D plans. CMS opioid use disorder benefit, mandated by SUPPORT Act 2018, requires Part D plans to include MAT generics on preferred tiers. Copays $0-$10 standard for generics. Brand Suboxone film and Sublocade typically tier-3 or tier-4 specialty with prior auth and step-therapy.
2026 CMS opioid use disorder benefit
CMS Medicare OUD Treatment mandates Part D coverage of FDA-approved MAT medications. 2026 implementation includes: $0-$10 generic buprenorphine preferred tier; reduced prior auth burden on first-line MAT; streamlined coverage for new starts in OUD treatment. CMS Star Ratings reward Part D plans for strong OUD medication adherence outcomes.
Medicare Extra Help (Low-Income Subsidy)
Medicare Extra Help / Low-Income Subsidy (LIS) is a federal program reducing Part D premiums and copays for income-eligible Medicare beneficiaries (typically below 150% Federal Poverty Level). Full LIS: $0 premium, $0 deductible, $0-$4.50 copay generics. Partial LIS: reduced premium and copays. Apply at SSA Extra Help.
Standalone Part D Plans (PDPs) vs MA-PD
Standalone Part D Prescription Drug Plans (PDPs) cover prescriptions alongside Original Medicare; premium $30-$50/month typical. Medicare Advantage with Part D (MA-PD plans) bundles Part D coverage into Medicare Advantage; often $0 premium for MA-PD beyond base Part B premium. For Original Medicare beneficiaries, standalone PDP enrollment required for prescription coverage. Compare plans at medicare.gov plan finder.
Sublocade extended-release coverage
Sublocade (extended-release buprenorphine injection, monthly) is covered under Part D for most plans with prior authorization. Step-therapy typically requires 30-60 day generic buprenorphine trial before approving Sublocade. Specialty pharmacy delivery standard; some plans use Limited Distribution Drugs (LDD) network. Monthly cost after prior auth approval: $20-$80 member copay typical with manufacturer assistance.
Brand vs generic buprenorphine
Generic sublingual buprenorphine-naloxone is bioequivalent to brand Suboxone per FDA. Generic on tier-1 of most Part D plans; brand on tier-2 or tier-3 with prior auth. FDA MAT Information confirms therapeutic equivalence. Patients prescribed brand should expect step-therapy requirement from Part D plan.
Methadone is NOT Part D — Part B at OTPs
Methadone for OUD is covered under Medicare Part B at SAMHSA-certified Opioid Treatment Programs (OTPs), not Part D. The 2018 SUPPORT Act added this Part B benefit. Buprenorphine and naltrexone are Part D (or Part B for Vivitrol injection). Common confusion: methadone for pain is covered under Part D; methadone for OUD is Part B at OTPs.
Naloxone (Narcan) coverage and SUPPORT Act
Naloxone nasal spray (Narcan) and injectable naloxone are covered under Part D for Medicare beneficiaries. SUPPORT Act 2018 expanded Naloxone access through over-the-counter availability (FDA-approved March 2023) — Part D coverage maintained. Most state Medicaid programs and many Part D plans cover naloxone at $0 copay as part of harm reduction efforts.
Part D coverage gap ("donut hole")
Historically, Part D had a coverage gap where members paid more for prescriptions after reaching annual coverage limit. The ACA largely eliminated the donut hole by 2020; further reductions in 2025 Inflation Reduction Act effectively closed it for most beneficiaries. 2026 Part D out-of-pocket maximum: $2,000 annual cap on member spending.
Standalone Part D plan choice 2026
Most states have 20-40 standalone Part D plans available. Key comparison factors for SUD-focused enrollee: generic buprenorphine tier placement; brand Suboxone/Sublocade prior auth pattern; preferred pharmacy network; monthly premium; deductible structure. Many SUD-conscious beneficiaries choose lower-premium plan with generic buprenorphine at preferred tier.
Recent Medicare Part D policy changes
The Inflation Reduction Act 2022 introduced major Part D changes: $2,000 annual out-of-pocket cap (2026); insulin $35 copay cap (2023); negotiated drug prices on top high-cost drugs (2026+ phase-in). For SUD beneficiaries, the $2,000 cap is particularly valuable for high-cost MAT regimens. CMS IRA Medicare resource details implementation.
What Does Medicare Part D Suboxone & Buprenorphine Coverage Cover for Addiction Treatment?
Medicare Part D Suboxone & Buprenorphine Coverage provides coverage for substance use disorder treatment as part of its behavioral health benefits. Under federal law — specifically the Mental Health Parity and Addiction Equity Act (MHPAEA) and the Affordable Care Act — Medicare Part D Suboxone & Buprenorphine Coverage is required to cover addiction treatment at the same level as other medical conditions.
This means your Medicare Part D Suboxone & Buprenorphine Coverage plan covers multiple levels of care, from initial detox through long-term outpatient support. The specific costs, referral requirements, and network restrictions depend on your plan type — see the plan comparison below.
At RehabHive, we work with Medicare Part D Suboxone & Buprenorphine Coverage daily and can verify your specific benefits in under 5 minutes. We will tell you exactly what is covered, what your out-of-pocket costs will be, and which treatment centers near you accept your plan.
Treatment Levels Covered by Medicare Part D Suboxone & Buprenorphine Coverage
Medicare Part D Suboxone & Buprenorphine Coverage covers 8 levels of addiction treatment.
Medicare Part D Suboxone & Buprenorphine Coverage Plan Types & Coverage
Your coverage level depends on your specific Medicare Part D Suboxone & Buprenorphine Coverage plan.
| Plan | Network Type | Pre-Auth Required | Out-of-Network |
|---|---|---|---|
| Standalone Part D Prescription Drug Plans (PDPs) | PPO/Open | Usually | ✓ Yes |
| Medicare Advantage with Part D (MA-PD plans) | PPO/Open | Usually | ✓ Yes |
| Medicare Extra Help (Low-Income Subsidy LIS) — Part D premium and copay assistance | PPO/Open | Usually | ✓ Yes |
| State Pharmaceutical Assistance Programs (SPAPs) — supplement Part D in some states | PPO/Open | Usually | ✓ Yes |
How to Verify Your Medicare Part D Suboxone & Buprenorphine Coverage Benefits
Follow these steps — or let us handle it all for you in 5 minutes.
Prefer online over calling? Submit your Medicare Part D Suboxone & Buprenorphine Coverage info below — we'll call you back within minutes with exact coverage details.
Verify Your Insurance Online
Free, confidential — results in under 5 minutes
Thank You!
A specialist will call you within 5 minutes to verify your benefits.
Can't wait? Call us now:
(833) 546-3513What Will You Pay Out-of-Pocket with Medicare Part D Suboxone & Buprenorphine Coverage?
Typical costs after Medicare Part D Suboxone & Buprenorphine Coverage coverage is applied.
| Treatment Level | In-Network Cost | Out-of-Network Cost | Typical Duration |
|---|---|---|---|
| Medical Detox | $0–$500 | $500–$2,000 | 3–7 days |
| Inpatient Rehab | $500–$3,000 | $2,000–$10,000 | 28–90 days |
| PHP | $200–$1,500 | $1,000–$5,000 | 4–8 weeks |
| IOP | $100–$1,000 | $500–$3,000 | 8–12 weeks |
| Outpatient | $20–$50/visit | $50–$150/visit | Ongoing |
| MAT | $10–$75/mo | $50–$200/mo | 6–24 months |
* Costs are estimates assuming deductible is met. Actual costs depend on your specific Medicare Part D Suboxone & Buprenorphine Coverage plan, facility, and location.
Treatment Centers — Verify Medicare Part D Suboxone & Buprenorphine Coverage Coverage
30 SAMHSA-verified facilities from our directory. Most accept Medicare Part D Suboxone & Buprenorphine Coverage under federal parity law. Call (833) 546-3513 to verify specific plan coverage at any center.
MD
Luminis Health Pathways Alcohol & Drug Treatment Center
Annapolis, MD
OH
LifeStance Health Dayton
Dayton, OH
WA
Behavioral Health Resources Shelton
Shelton, WA
CA
Didi Hirsch Mental Health Services Jump Street
Los Angeles, CA
IL
Near North Health Denny Community Health Center
Chicago, IL
Ka Hale Pomaikai
Kaunakakai, HI
MI
Recover
Muskegon, MI
CT
Root Center for Advanced Recovery Hartford Dispensary/Bristol Clinic
Bristol, CT
Omada Behavioral Health Services
Northfield, MN
CA
Teen Challenge Bradford House Men's Center
Oakland, CA
ID
Challis Area Health Center
Challis, ID
Dutiful Angels Trydent Services
Las Vegas, NV
WI
Reflections Mental Health
Madison, WI
OH
The Care Clinic Cincinnati
Cincinnati, OH
Methodist Richardson Medical Center Richardson
Richardson, TX
Pawnee Mental Health Services Beloit
Beloit, KS
OH
Lighthouse Behavioral Health
Reynoldsburg, OH
IN
Groups Recover Together Columbus
Columbus, IN
AZ
Arizona Behavioral counselling & education
Chandler, AZ
PA
Positive Pathways Pennsylvania
Pittsburgh, PA
CA
Northeast Health Services - Attleboro
San Mateo, CA
OH
Kids Thrive Behavioral Health
Cincinnati, OH
NJ
Health Wellness Synergy Center
Fort Lee, NJ
Pro Health Solutions
Silver Spring, MD
TN
Crossroads Treatment Center Oak Ridge
Oak Ridge, TN
CA
Ranch Creek Recovery
Murrieta, CA
PA
Legends Treatment Center of Pittsburgh
Pittsburgh, PA
KS
Smoky Hill Foundation for Chemical Dep
Hays, KS
IA
Pathways Behavioral Services
Waterloo, IA
UT
Neurobehavioral Center for Growth
Bountiful, UT
Medicare Part D Suboxone & Buprenorphine Coverage & Rehab: FAQ
Answers to the most asked questions about Medicare Part D Suboxone & Buprenorphine Coverage coverage.
Does Medicare cover Suboxone?
How much does Suboxone cost with Medicare?
Do I need a separate Part D plan for Suboxone?
Does Medicare cover Sublocade?
Does Part D cover methadone?
What is Medicare Extra Help?
Does Medicare cover naloxone (Narcan)?
How do I find the best Part D plan for Suboxone?
Can I switch Part D plans for better Suboxone coverage?
Does Part D cover Vivitrol?
Your Rights with Medicare Part D Suboxone & Buprenorphine Coverage
Mental Health Parity Act
Medicare Part D Suboxone & Buprenorphine Coverage must cover addiction treatment at the same level as physical health conditions. They cannot impose higher copays, stricter visit limits, or more restrictive pre-authorization for rehab.
Right to Appeal
If Medicare Part D Suboxone & Buprenorphine Coverage denies your claim, you have the legal right to appeal. Request a written explanation and file a formal appeal. Many denials are overturned — especially with supporting documentation from your treatment provider.
Sources
- U.S. Department of Labor — Mental Health Parity and Addiction Equity Act
- HealthCare.gov — Mental Health & Substance Abuse Coverage
- SAMHSA — National Helpline (1-800-662-4357)
Last updated: March 17, 2026 • Reviewed by RehabHive editorial team
Verify Your Medicare Part D Suboxone & Buprenorphine Coverage Coverage in Under 5 Minutes
Free. Confidential. No obligation. Two ways to start:
